A bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.
About This Bill
Committee
Latest Action · July 10, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.